跳至主要内容
临床试验/NCT01497639
NCT01497639已完成不适用

Comparison of the Efficacy of Double Monopolar Versus Interleaving Stimulation Modes for the Deep Brain Stimulation Treatment of Primary Generalized or Segmental Dystonia

University of Pecs2 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2012年3月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
34
试验地点
2
主要终点
Differences in severity of dystonia

研究概览

简要总结

The aim of the study is to compare the efficacy and the safety profile of the newly introduced interleaving stimulation mode to those of the standard double monopolar stimulation mode during pallidal deep brain stimulation of primary generalized or segmental dystonia.

详细描述

Background:

For the treatment of drug-refractory dystonia, bilateral pallidal deep brain stimulation (GPi-DBS) is proven to be an efficient option. On average, 40-55% improvement on dystonia rating scales (DRS) could be achieved according to the results of multicenter trials lasting for years. However, a considerable portion (10-25%) of the patients experience minimal alleviation despite of good electrode placement. These patients can be regarded as non-responders to GPi-DBS defined as having either limited improvement (< 25% on DRS) or worsening. Besides adjusting the amplitude, frequency or pulse-width of stimulation, one can change the electrode configuration from the commonly applied single monopolar stimulation mode (one contact on the electrode is negative) to either double monopolar stimulation (two -usually adjacent- negative contacts on the electrode are stimulated with same amplitude and pulse-width values) or bipolar stimulation mode (one contact on the electrode is positive) in case of unsatisfactory outcomes. Although these techniques had been utilized in multicenter trials, non-responsiveness to GPi-DBS did occur. Recently the investigators have reported in the Movement Disorders that the newly introduced interleaving stimulation mode was superior to single or double monopolar stimulation in four patients who had initially (6-12 months after implantation) limited response to GPi DBS.

Aims of the study:

To systematically compare the efficacy and the side-effect profile of double monopolar stimulation mode to those of interleaving stimulation mode in a prospective, randomized, double-blind, and cross-over study.

Methods:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
7 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ages of 7 and 75 years
  • marked disability owing to primary generalized or segmental dystonia, despite optimal pharmacologic treatment
  • disease duration of at least 5 years.

排除标准

  • previous brain surgery;
  • cognitive impairment (< 120 points on the Mattis Dementia Rating Scale)
  • moderate-to-severe depression (> 25 points on the Beck Depression Inventory)
  • marked brain atrophy as detected by magnetic resonance imaging
  • other medical or psychiatric coexisting disorders that could increase the surgical risk or interfere with completion of the trial

研究组 & 干预措施

Process 1

Active Comparator
  • Visit 1: Baseline evaluation (maximum 1 week before operation)
  • Visit 2: Testing of electrodes and subsequent initiation of interleaving stimulation mode (4th postoperative week).
  • Visit 3 Evaluation and cross-over to double-monopolar stimulation mode (16th postoperative week).
  • Visit 4 Final evaluation. (28th postoperative week).

干预措施: Interleaving stimulation mode (Medtronic) (Device)

Process 1

Active Comparator
  • Visit 1: Baseline evaluation (maximum 1 week before operation)
  • Visit 2: Testing of electrodes and subsequent initiation of interleaving stimulation mode (4th postoperative week).
  • Visit 3 Evaluation and cross-over to double-monopolar stimulation mode (16th postoperative week).
  • Visit 4 Final evaluation. (28th postoperative week).

干预措施: Double monopolar stimulation mode (Medtronic) (Device)

Process 2

Active Comparator
  • Visit 1: Baseline evaluation (maximum 1 week before operation)
  • Visit 2: Testing of electrodes and subsequent initiation of double-monopolar stimulation mode (4th postoperative week).
  • Visit 3 Evaluation and cross-over to interleaving stimulation mode (16th postoperative week).
  • Visit 4 Final evaluation. (28th postoperative week).

干预措施: Interleaving stimulation mode (Medtronic) (Device)

Process 2

Active Comparator
  • Visit 1: Baseline evaluation (maximum 1 week before operation)
  • Visit 2: Testing of electrodes and subsequent initiation of double-monopolar stimulation mode (4th postoperative week).
  • Visit 3 Evaluation and cross-over to interleaving stimulation mode (16th postoperative week).
  • Visit 4 Final evaluation. (28th postoperative week).

干预措施: Double monopolar stimulation mode (Medtronic) (Device)

结局指标

主要结局

Differences in severity of dystonia

时间窗: 7 months

Differences in severity of dystonia measured by Burke-Fahn-Marsden Dystonia Rating Scale

次要结局

  • Health-related quality of life after three months deep brain stimulation(7 months)
  • Side-effect profile after three months deep brain stimulation(7 months)
  • Number of treatment responders after three months deep brain stimulation(7 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Norbert Kovacs

Associate professor, specialist in neurology and movement disorders, Department of Neurology

University of Pecs

研究点 (2)

Loading locations...

相似试验